Summary
Quest Diagnostics Inc. (DGX) announced its financial results for the quarter ended September 30, 2021, on October 21, 2021. This 8-K filing primarily serves to incorporate by reference a press release detailing these quarterly results. Investors should refer to Exhibit 99.1 for the specific financial performance, operational updates, and any forward-looking statements made by the company for the third quarter of 2021. While the 8-K itself does not contain detailed financial figures, it signals that Quest Diagnostics has disclosed its performance for the period. Key information investors would typically seek from such a release includes revenue, earnings per share (EPS), profit margins, and any commentary on business trends, such as demand for COVID-19 testing and its impact on overall revenue, as well as performance in other diagnostic areas. The filing directs investors to the attached press release for these critical details.
Key Highlights
- 1Quest Diagnostics (DGX) filed an 8-K on October 21, 2021, to report its financial results for the quarter ended September 30, 2021.
- 2The 8-K filing incorporates by reference a press release (Exhibit 99.1) which contains the detailed financial and operational results for the quarter.
- 3Investors are directed to the press release for specific performance metrics, including revenue, earnings, and profit margins for Q3 2021.
- 4The filing does not provide the actual financial figures but serves as notification of their release.
- 5Key performance indicators and business trends for the quarter are detailed in the referenced press release.